Symbol="CTMX"
AssetType="Common Stock"
Name="CytomX Therapeutics Inc"
Description="CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. The company is headquartered in South San Francisco, California."
CIK="1501989"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="97481000"
EBITDA="-38084000"
PERatio="None"
PEGRatio="-1.8"
BookValue="-1.273"
DividendPerShare="0"
DividendYield="0"
EPS="-0.63"
RevenuePerShareTTM="1.201"
ProfitMargin="-0.531"
OperatingMarginTTM="-0.51"
ReturnOnAssetsTTM="-0.108"
ReturnOnEquityTTM="-54.75"
RevenueTTM="79493000"
GrossProfitTTM="53163000"
DilutedEPSTTM="-0.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.924"
AnalystTargetPrice="2.49"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.447"
PriceToBookRatio="3.806"
EVToRevenue="0.743"
EVToEBITDA="0.694"
Beta="0.625"
num_52WeekHigh="3.02"
num_52WeekLow="1.17"
num_50DayMovingAverage="1.658"
num_200DayMovingAverage="1.835"
SharesOutstanding="66768000"
DividendDate="None"
ExDividendDate="None"
symbol="CTMX"
open="1.49"
high="1.50"
low="1.43"
price="1.46"
volume="117923.00"
latest_trading_day="2023-08-25"
previous_close="1.48"
change="-0.02"
change_percent="-1.3514%"
aroon_positive_momentum_days="14"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="14"
Volume_recent_avg="372117"
Change_recent_avg="0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="14"
Aroon_momentum_negative="86"
image_negative_thumbnail_id_1="1136"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_negative_thumbnail_id_2="1094"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="999"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0161.jpeg"
image_positive_thumbnail_id_2="617"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0091.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
